214 related articles for article (PubMed ID: 33188829)
1. Cyclodextrin based natural nanostructured carbohydrate polymers as effective non-viral siRNA delivery systems for cancer gene therapy.
Mousazadeh H; Pilehvar-Soltanahmadi Y; Dadashpour M; Zarghami N
J Control Release; 2021 Feb; 330():1046-1070. PubMed ID: 33188829
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
Li J; Loh XJ
Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable Polyester of Poly (Ethylene glycol)-sebacic Acid as a Backbone for β -Cyclodextrin-polyrotaxane: A Promising Gene Silencing Vector.
Ghodke S; Mahajan P; Gupta K; Ver Avadhani C; Dandekar P; Jain R
Curr Gene Ther; 2019; 19(4):274-287. PubMed ID: 31393245
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
[TBL] [Abstract][Full Text] [Related]
5. Cellular internalization and gene silencing of siRNA polyplexes by cytocleavable cationic polyrotaxanes with tailored rigid backbones.
Tamura A; Yui N
Biomaterials; 2013 Mar; 34(10):2480-91. PubMed ID: 23332177
[TBL] [Abstract][Full Text] [Related]
6. Supramolecular polymers based on cyclodextrins for drug and gene delivery.
Li JJ; Zhao F; Li J
Adv Biochem Eng Biotechnol; 2011; 125():207-49. PubMed ID: 20839082
[TBL] [Abstract][Full Text] [Related]
7. Functionalized non-viral cationic vectors for effective siRNA induced cancer therapy.
Gupta K; Puri A; Shapiro BA
DNA RNA Nanotechnol; 2017 May; 4(1):1-20. PubMed ID: 34322587
[TBL] [Abstract][Full Text] [Related]
8. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability.
Godinho BM; Ogier JR; Quinlan A; Darcy R; Griffin BT; Cryan JF; O'Driscoll CM
Int J Pharm; 2014 Oct; 473(1-2):105-12. PubMed ID: 24992319
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis.
Gooding M; Malhotra M; McCarthy DJ; Godinho BM; Cryan JF; Darcy R; O'Driscoll CM
Eur J Pharm Sci; 2015 Apr; 71():80-92. PubMed ID: 25703259
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications.
O'Mahony AM; Doyle D; Darcy R; Cryan JF; O'Driscoll CM
Eur J Pharm Sci; 2012 Dec; 47(5):896-903. PubMed ID: 23022516
[TBL] [Abstract][Full Text] [Related]
11. Polyrotaxanes for applications in life science and biotechnology.
Li JJ; Zhao F; Li J
Appl Microbiol Biotechnol; 2011 Apr; 90(2):427-43. PubMed ID: 21360153
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin-based host-guest supramolecular nanoparticles for delivery: from design to applications.
Hu QD; Tang GP; Chu PK
Acc Chem Res; 2014 Jul; 47(7):2017-25. PubMed ID: 24873201
[TBL] [Abstract][Full Text] [Related]
13. Folate appended cyclodextrins for drug, DNA, and siRNA delivery.
Ceborska M
Eur J Pharm Biopharm; 2017 Nov; 120():133-145. PubMed ID: 28893691
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin-Based Polymeric Drug Delivery Systems for Cancer Therapy.
Li X; Liu J; Qiu N
Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987181
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin based rotaxanes, polyrotaxanes and polypseudorotaxanes and their biomedical applications.
García-Río L; Otero-Espinar FJ; Luzardo-Alvarez A; Blanco-Méndez J
Curr Top Med Chem; 2014; 14(4):478-93. PubMed ID: 24354671
[TBL] [Abstract][Full Text] [Related]
16. Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery.
O'Mahony AM; Ogier J; Darcy R; Cryan JF; O'Driscoll CM
PLoS One; 2013; 8(6):e66413. PubMed ID: 23805220
[TBL] [Abstract][Full Text] [Related]
17. Drug Carrier Systems Based on Cyclodextrin Supramolecular Assemblies and Polymers: Present and Perspectives.
Gonzalez-Gaitano G; Isasi JR; Velaz I; Zornoza A
Curr Pharm Des; 2017; 23(3):411-432. PubMed ID: 27855609
[TBL] [Abstract][Full Text] [Related]
18. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
[TBL] [Abstract][Full Text] [Related]
19. Cellular delivery of polynucleotides by cationic cyclodextrin polyrotaxanes.
Dandekar P; Jain R; Keil M; Loretz B; Muijs L; Schneider M; Auerbach D; Jung G; Lehr CM; Wenz G
J Control Release; 2012 Dec; 164(3):387-93. PubMed ID: 22789529
[TBL] [Abstract][Full Text] [Related]
20. Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.
O'Mahony AM; Godinho BM; Ogier J; Devocelle M; Darcy R; Cryan JF; O'Driscoll CM
ACS Chem Neurosci; 2012 Oct; 3(10):744-52. PubMed ID: 23077718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]